Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Diets that boost ketone production are increasingly used for treating several neurological disorders. Elevation in ketones in most cases is considered favorable, as they provide energy and are efficient in fueling the body’s energy needs. Despite all the benefits from ketones, the above normal elevation in the concentration of ketones in the circulation tend to illicit various pathological complications by activating injurious pathways leading to cellular damage. Recent literature demonstrates a plausible link between elevated levels of circulating ketones and oxidative stress, linking hyperketonemia to innumerable morbid conditions. Ketone bodies are produced by the oxidation of fatty acids in the liver as a source of alternative energy that generally occurs in glucose limiting conditions. Regulation of ketogenesis and ketolysis plays an important role in dictating ketone concentrations in the blood. Hyperketonemia is a condition with elevated blood levels of acetoacetate (AA), 3-β-hydroxybutyrate (BHB), and acetone. Several physiological and pathological triggers, such as fasting, ketogenic diet, and diabetes cause an accumulation and elevation of circulating ketones. Complications of the brain, kidney, liver, and microvasculature were found to be elevated in diabetic patients who had elevated ketones compared to those diabetics with normal ketone levels. This review summarizes the mechanisms by which hyperketonemia and ketoacidosis cause an increase in redox imbalance and thereby increasing the risk of morbidity and mortality in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036 · cited 1×
“However, in adults, 12–16 h of fasting can cause a moderate increase in ketone levels while fasting for upto 3 days can attain hyperketonemia [106, 107].”
Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497 · cited 3×
“It is becoming clear that the elevated levels of oxidative stress experienced by diabetic patients can increase the oxidation of LDL and thereby promote or increase their risk for atherosclerosis and CVD. Studies from our lab have shown that hyperketonemia can bring about an increase in the lipid peroxidation in T1D p…”
InfluentialNeuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445
Banerji, M. A., Chaiken, R. L., Huey, H., Tuomi, T., Norin, A. J., Mackay, I. R., Rowley, M. J., Zimmet, P. Z., & Lebovitz, H. E. (1994) · Diabetes · doi:10.2337/diab.43.6.741 · Cited by 266
Cameron, F. J., Scratch, S. E., Nadebaum, C., Northam, E. A., Koves, I., Jennings, J., Finney, K., Neil, J. J., Wellard, R. M., Mackay, M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1904 · Cited by 241 · cited 1×
“Recent studies using MRI measures show altered brain structure and injury associated with adverse neurocognitive outcomes, including impairment in neuronal function and viability in T1D children [69, 70].”
The Ketogenic diet: from molecular mechanisms to clinical effects
(2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.10.003 · Cited by 213 · cited 1×
“diet is most commonly prescribed to patients with refractory epilepsy or other neurological conditions [82-84].”
Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells
Ferdaoussi, M., Dai, X., Jensen, M. V., Wang, R., Peterson, B. S., Huang, C., Ilkayeva, O., Smith, N., Miller, N., Hajmrle, C., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82498 · Cited by 169 · cited 1×
“It has been shown with in vitro islet studies that the glucose dependent amplification of insulin exocytosis and thereby its secretion was blunted with free fatty acid treatment [50, 51].”
Bonnefont, J. P., Specola, N. B., Vassault, A., Lombes, A., Ogier, H., de Klerk, J. B. C., Munnich, A., Coude, M., Paturneau-Jouas, M., & Saudubray, J. M. (1990) · European Journal of Pediatrics · doi:10.1007/bf02072043 · Cited by 168
Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes
Stephens, J. M., Sulway, M. J., & Watkins, P. J. (1971) · Diabetes · doi:10.2337/diab.20.7.485 · Cited by 99
Saudubray, J. M., Marsac, C., Limal, J. M., Dumurgier, E., Charpentier, C., Ogier, H., & Coudè, F. X. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80583-5 · Cited by 53 · cited 2×
“In young children having very high energy demands, even a day’s fast or infections can increase the production of ketone bodies causing hyperketonemia [104, 105].”
Cited by
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
Ketogenic diets and chronic disease: weighing the benefits against the risks
Crosby, L., Davis, B., Joshi, S., Jardine, M., Paul, J., Neola, M., & Barnard, N. D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.702802 · Cited by 229
Metabolomic analysis in inflammatory bowel disease: A systematic review
Gallagher, K., Catesson, A., Griffin, J. L., Holmes, E., & Williams, H. R. T. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa227 · Cited by 133
Ketosis-prone diabetes (Flatbush diabetes): an emerging worldwide clinically important entity
Lebovitz, H. E., & Banerji, M. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1075-4 · Cited by 98
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou, M., Lambadiari, V., Roden, M., & Dimitriadis, G. D. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnae032 · Cited by 90
Metadata
- Authors
- Kanikarla-Marie, P., & Jain, S. K.
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 95
- Pages
- 268-277
- ISSN
- 0891-5849 (ISSN-L)
- OpenAlex
- W2327942470
- Cited by
- 194
- References
- 10
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes. https://app.cochat.ai/papers/10.1016/j.freeradbiomed.2016.03.020
- The paper
- Kanikarla-Marie, P., & Jain, S. K. (2016). Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2016.03.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.